John-Paul Kilday

John completed his undergraduate medical training from The University of Glasgow in 1998. He underwent paediatric oncology training in various UK specialist centres including Addenbrookes Hospital Cambridge, Great Ormond Street Hospital London, Oxford Children’s Hospital and Queen’s Medical Centre, Nottingham. From 2007-2011, Dr Kilday was the James Tudor Clinical Research Fellow in Paediatric Neuro-oncology at the Children’s Brain Tumour Research Centre, Nottingham where he was awarded a PhD for his work assessing the genomic and epigenetic characteristics of paediatric ependymoma. In 2012, he was awarded an International Neuro-oncology Fellowship on the Brain Tumour Programme at The Hospital for Sick Children, Toronto. During this time he published several clinical analyses and reviews on a range of childhood brain tumours.


Chair of the North West Neuro-oncology Clinical Network
Vice-Chair of the UK CCLG Neuro-oncology division

Paediatric Neuro-oncology – specifically paediatric ependymoma, paediatric low grade glioma, paediatric craniopharyngioma, tumour biology.

Since 2013, John has led the clinical Paediatric Neuro-oncology service at the Royal Manchester Children’s Hospital. He is an Honorary Senior Lecturer at The University of Manchester and also an Honorary Consultant Paediatric Oncologist at The Christie Hospital, Manchester. He is the creator and founder member of the Children’s Brain Tumour Research Network in Manchester, Vice-Chair of the UK CCLG Neuro-oncology division and core member of the SIOP-E paediatric ependymoma and low grade glioma groups.